Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 14/20 | 0.41 |
| ▸ | CPB1 | P15086 | 8/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30786466 | 0.87 | CPB2 (0.37) | CPB2CPB1 | |
| SCHEMBL18346836 | 0.86 | CPB2 (0.42) | CPB2CPB1 | |
| SCHEMBL25469012 | 0.86 | CPB2 (0.42) | CPB2CPB1 | |
| SCHEMBL20759177 | 0.85 | CPB2 (0.39) | CPB2CPB1 | |
| SCHEMBL30643159 | 0.84 | CPB2 (0.36) | CPB2CPB1 | |
| SCHEMBL10659919 | 0.83 | CPB2 (0.46) | CPB2CPB1 | |
| SCHEMBL3008885 | 0.81 | ITGB3 (0.45) | CPB2CPB1 | |
| SCHEMBL3008889 | 0.81 | ITGB3 (0.45) | CPB2CPB1 | |
| SCHEMBL13650201 | 0.81 | ITGB3 (0.45) | CPB2CPB1 | |
| SCHEMBL7001068 | 0.81 | SLC7A5 (0.44) | SLC7A5CPB2CPB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3916000-B1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTING GROUP-FORMING REAGENT, AND AROMATIC HETEROCYCLIC COMPOUND | FUJIFILM CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | GENMAB AS (DK) | 2026-02-05 | — | — | US | disclosed |
| EP-4598592-A1 | A COMPOUND AND ITS USE FOR DETECTING A DISEASE IN THE EXHALED BREATH OF A SUBJECT | Owlstone Medical Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| US-12325727-B2 | Method for producing peptide compound, protective group-forming reagent, and aromatic heterocyclic compound | FUJIFILM CORPORATION (JP) | 2025-06-10 | — | — | US | disclosed |
| US-12227542-B2 | Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound | FUJIFILM CORPORATION (JP) | 2025-02-18 | — | — | US | disclosed |
| US-20240325561-A1 | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS | SEAGEN INC (US) | 2024-10-03 | — | — | US | disclosed |
| US-20240261427-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. | 2024-08-08 | — | — | US | disclosed |
| US-20240245796-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. | 2024-07-25 | — | — | US | disclosed |
| US-20240207429-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-06-27 | — | — | US | disclosed |
| US-20240207418-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. | 2024-06-27 | — | — | US | disclosed |
| EP-4269422-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-112010961-B | Solid-liquid synthesis method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| WO-2023068296-A1 | METHOD FOR PRODUCING COMPOUNDS, METHOD FOR PRODUCING COMPOUND LIBRARY, COMPOUND LIBRARY, AND SCREENING METHOD | 国立大学法人東京大学 | 2023-04-27 | — | — | WO | disclosed |
| WO-2022138891-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | 中外製薬株式会社 | 2022-06-30 | — | — | WO | disclosed |
| EP-3992187-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND FUSED POLYCYCLIC COMPOUND | FUJIFILM Corporation (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-20220112234-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND | FUJIFILM CORPORATION (JP) | 2022-04-14 | — | — | US | disclosed |
| US-20220072146-A1 | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS | SEAGEN INC (US) | 2022-03-10 | — | — | US | disclosed |
| WO-2019139028-A1 | RESIN COMPOSITION FOR INSULATING FILM | 日産化学株式会社 | 2019-07-18 | — | — | WO | disclosed |
| EP-1242420-A2 | AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ELI LILLY AND COMPANY (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001044247-A2 | AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ELI LILLY AND COMPANY (US) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227542-B2 | Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound | C9, GRPR, VIP | SLC7A5 2929/4885CPB2 803/4885CPB1 1295/4885 |
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | CSGALNACT1, SLC43A1, OSTC | SLC7A5 54/4885CPB2 2596/4885CPB1 2091/4885 |
| US-20240207418-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PAICS, DHFR, CD44 | SLC7A5 378/4885CPB2 2555/4885CPB1 2381/4885 |
| US-20220072146-A1 | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS | EGFR, HDGF, CD47 | SLC7A5 318/4885CPB2 3396/4885CPB1 3113/4885 |
| US-12325727-B2 | Method for producing peptide compound, protective group-forming reagent, and aromatic heterocyclic compound | HM13, MCHR1, QRFPR | SLC7A5 2326/4885CPB2 1191/4885CPB1 713/4885 |
| US-20240207429-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PAICS, DHFR, CD44 | SLC7A5 378/4885CPB2 2555/4885CPB1 2381/4885 |
| US-20240325561-A1 | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS | EGFR, HDGF, CD47 | SLC7A5 316/4885CPB2 3379/4885CPB1 3105/4885 |
| US-20240261427-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PAICS, DHFR, CD44 | SLC7A5 378/4885CPB2 2555/4885CPB1 2381/4885 |
| US-20240245796-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PAICS, DHFR, CD44 | SLC7A5 378/4885CPB2 2555/4885CPB1 2381/4885 |
| US-20220112234-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND | C9, GRPR, VIP | SLC7A5 2929/4885CPB2 803/4885CPB1 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.